The New Biology of Lung Cancer: Changing Paradigms in Personalized Medicine

Physicians Education Resource
Archivo
-
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
 
Contenido de curso
CME-certified satellite symposium, will inform participants of the emerging diversity of lung cancer and the implications for individualized therapy. The newfound importance of biomarkers in treatment decision making will be emphasized, followed by other current topics of interest, such as maintenance therapy. Selected use of targeted agents, including EGFR and angiogenesis inhibitors, will be discussed, as will novel targets including EML4-ALK. Didactic lectures from lung cancer experts will...
Objetivos de formación
Please see our websie for all the details www.cancerlearning.com
Destinatario
This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health
Observaciones
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/541
 

Información e inscripción:

Mr. Duane Fowler
 
Categorías
Oncología
Idioma
Inglés
Costos
complimentary
Cantacto organizador
3500 Maple Ave. Ste. 700
75219 Dallas
USA
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Alumni Club Medizinische Universität WienEuropean Public Health Association (EUPHA)Ärzte der WeltAnästhesie in Entwicklungsländern e. V.Center of ExcellenceCharité International AcademyÄrztekammer für WienAMREF - African Medical and Research Foundation